Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients

Carcinogenesis

Volumn 36, Issue 12, 2015, Pages 1474-1483

  Toiyama, Yuji ^a,b   Tanaka, Koji ^a   Kitajima, Takahito ^a   Shimura, Tadanobu ^a   Imaoka, Hiroki ^a   Mori, Koichiro ^a   Okigami, Masato ^a   Yasuda, Hiromi ^a   Okugawa, Yoshinaga ^a,b   Saigusa, Susumu ^a   Ohi, Masaki ^a   Inoue, Yasuhiro ^a   Mohri, Yasuhiko ^a   Goel, Ajay ^b   Kusunoki, Masato ^a  

^a MIE UNIVERSITY   (Japan)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGPTL2 PROTEIN, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ANOIKIS; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; CELL PROLIFERATION; DISEASE FREE SURVIVAL; EARLY CANCER DIAGNOSIS; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; STOMACH NEOPLASMS; TUMOR CELL LINE; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETINS; ANOIKIS; AREA UNDER CURVE; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ROC CURVE; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84949793740     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv139     Document Type: Article

References (38)

1. Nagini, S. (2012) Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J. Gastrointest. Oncol., 4, 156-169.
2. de Martel, C. et al. (2013) Gastric cancer: epidemiology and risk factors. Gastroenterol. Clin. North Am., 42, 219-240.
3. Lustosa, S.A. et al. (2008) Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials. Acta Cir. Bras., 23, 520-530.
4. Benchimol, S. et al. (1989) Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell, 57, 327-
5. Guadagni, F. et al. (1992) CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma. Cancer Res., 52, 1222-1227.
6. Steinberg, W. (1990) The clinical utility of the CA 19-9 tumor-associated antigen. Am. J. Gastroenterol., 85, 350-355.
7. Grivennikov, S.I. et al. (2010) Immunity, inflammation, and cancer. Cell, 140, 883-899.
8. de Martel, C. et al. (2009) Infections and cancer: established associations and new hypotheses. Crit. Rev. Oncol. Hematol., 70, 183-194.
9. Dostert, C. et al. (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science, 320, 674-677.
10. Aballay, L.R. et al. (2013) Overweight and obesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America. Nutr. Rev., 71, 168-179.
11. Beyaert, R., et al. (2013) Cancer risk in immune-mediated inflammatory diseases: IMID and Cancer Risk. Mol Cancer, 12,
12. 12. De Paoli, P. et al. (2013) Carcinogenic viruses and solid cancers without sufficient evidence of causal association. Int. J. Cancer, 133, 1517-1529.
13. Correa, P. (1995) Helicobacter pylori and gastric carcinogenesis. Am. J. Surg. Pathol., 19 Suppl 1, S37-S43.
14. Correa, P., et al. (1994) Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res., 54, 1941s-1943s.
15. Moenner, M. et al. (2007) Integrated endoplasmic reticulum stress responses in cancer. Cancer Res., 67, 10631-10634.
16. Baird, M. et al. (2013) The unfolded protein response is activated in Helicobacter-induced gastric carcinogenesis in a non-cell autonomous manner. Lab. Invest., 93, 112-122.
17. Tabata, M. et al. (2009) Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab., 10, 178-188.
18. Aoi, J. et al. (2011) Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Cancer Res., 71, 7502-7512.
19. Endo, M. et al. (2012) Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer Res., 72, 1784-
20. 20. Usui, T. et al. (2013) Angiopoietin-like protein 2 is associated with chronic kidney disease in a general Japanese population: the Hisayama Study. Circ. J., 77, 2311-2317.
21. Doi, Y. et al. (2013) Angiopoietin-like protein 2 and risk of type 2 diabetes in a general Japanese population: the Hisayama study. Diab. Care, 36, 98-100.
22. Ide, S. et al. (2015) Angiopoietin-like protein 2 acts as a novel biomarker for diagnosis and prognosis in patients with esophageal cancer. Ann. Surg. Oncol., 22, 2585-2592.
23. Toiyama, Y. et al. (2014) Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence. Clin. Cancer Res., 20, 6175-6186.
24. Yoshinaga, T. et al. (2015) Angiopoietin-like protein 2 is a potential biomarker for gastric cancer. Mol. Med. Rep., 11, 2653-2658.
25. Japanese-Gastric-Cancer-Association (2011) Japanese Classificacion of Gastric Carcinoma: 3rd English edition. Gastric Cancer, 14, 101-112.
26. Sato, R. et al. (2015) Angiopoietin-like protein 2 induces androgenindependent and malignant behavior in human prostate cancer cells. Oncol. Rep., 33, 58-66.
27. Gao, L. et al. (2015) ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma. J. Gastroenterol. Hepatol., 30, 396-404.
28. Liu, X., et al. (2014) ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells. Oncotarget, 6, 21004-21015.
29. Carbone, C. et al. (2015) An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis. Oncotarget, 6, 13822-13834.
30. Sasaki, H. et al. (2012) Angiopoietin-like protein ANGPTL2 gene expression is correlated with lymph node metastasis in lung cancer. Oncol. Lett., 4, 1325-1328.
31. Zhou, J. et al. (2014) Angiopoietin-like protein 2 negatively regulated by microRNA-25 contributes to the malignant progression of colorectal cancer. Int. J. Mol. Med., 34, 1286-1292.
32. He, X.X. et al. (2014) Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties. Oncol. Rep., 32, 1200-1210.
33. He, C.Z. et al. (2013) Serum protein and genetic tumor markers of gastric carcinoma. Asian Pac. J. Cancer Prev., 14, 3437-3442.
34. Muramoto, A. et al. (2011) Angiopoietin-like protein 2 sensitively responds to weight reduction induced by lifestyle intervention on overweight Japanese men. Nutr. Diab., 1, e20.
35. Li, Q. et al. (2013) Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes. Diab. Res. Clin. Pract., 100, 385-
36. 36. Meng, Q.X. et al. (2013) Association of serum angiopoietin-like protein 2 and epinephrine levels in metabolically healthy but obese individuals: and evidence. Exp. Ther. Med., 5, 1631-1636.
37. Endo, M. et al. (2014) Serum ANGPTL2 levels reflect clinical features of breast cancer patients: implications for the pathogenesis of breast cancer metastasis. Int. J. Biol. Markers, 29, e239-e245.
38. Catalán, V. et al. (2013) Adipose tissue immunity and cancer. Front. Physiol., 4,